《即日市評》恆指收市跌至半年低 科網及藥股受壓
市場觀望美聯儲本周議息,金管局收市後公布本港8月底綜合利率升至0.75厘(按花旗上月報告曾指歷史上港銀融資本成本若升至0.7厘水平時,最優惠利率將上調)。受科網股拖累下,恆指今日向下。美股道指及納指上周五(16日)各跌0.45%及0.9%;執筆之時美國十年期國債孳息率跌至3.452厘,美匯指數最新跌至110.05,道指期貨最新跌198點或0.66%,納指期貨最新跌0.84%。摩通亞洲區貨幣指數跌0.42%報98.69,人民幣即期收跌13點報7.0179兌一美元,上證綜指今日跌10點或0.35%收3,115點,深證成指跌0.5%,滬深兩市成交額6,653億人民幣。
恆指低開66點後,反覆於18,600附近徘徊,午後曾跌267點一度低見18,494點,全日跌195點或1.04%,收18,565點,收市計創半年低位;國指全日跌82點或1.28%,收6,338點;恆生科技指數跌79點或2.07%,收3,778點。大市全日成交總額910.44億元,滬、深港通南下交易分別淨流入15.06億及淨流出11.82億元人民幣。醫藥股下滑,中生製藥(01177.HK)跌近6.9%,藥明生物(02269.HK)挫5%。
【醫藥股走弱 科網股造淡】
市場關注美方審計中概股底稿,科網股造淡,阿里巴巴(09988.HK)股價走低3.6%收83.7元,京東(09618.HK)跌2.5%,網易(09999.HK)及嗶哩嗶哩(09626.HK)股價各下滑3.6%及5.6%,而蔚萊(09866.HK)股價挫近6.4%。據《環球時報》綜合外媒消息指,美國證券交易委員會主席根斯勒披露,美國上市公司會計監督委員會(PCAOB)的工作人員預計今日(19日)開始檢查在美上市中概股的審計底稿。根斯勒在參議院銀行委員會聽證會上稱,整個過程需要8到10周,或在2022年12月初得出檢查結果。
美銀證券發表報告指,由於零售行業仍受到宏觀不確定性的影響,美銀預期內地科網股較為關注效率提升及成本控制,預期對銷售及營運推廣費用、返利及補貼等會更重視。該行又相信,電商及互聯網企業明年需要在利潤率表現上有顯著改善,才能滿足市場普遍的預期。
【跌股千二隻 周大福彈高】
港股今日市寬續弱,主板股票升跌比率為11比30(上日為11比29),下跌股份1,274隻(跌幅2.8%);恆指成份股今日19隻股份上升,下跌股份49隻,升跌比率為26比67(上日為38比56)。大市今日錄沽空160.16億元,佔可沽空股份成交額758.63億元的21.112%(上日為20.559%)。
周大福(01929.HK)股價升6.2%收15.38元。摩根大通發表報告指,將周大福投資評級由「減持」一舉上調至「增持」,目標價由12元升至19元,但提醒股價可能會在短期內因內地部分地區限制出行,而面臨一定壓力,相信市場競爭緩和以及公司新產品穩定推出,將有助於今年維持盈利雙位數增長。
摩通認為周大福通過特許經營模式專注於低線城市的門店擴張,將顯著稀釋其利潤率並導致盈利增長弱於預期,但隨著新任副董事長任命及業務戰略重新聚焦於鑲嵌珠寶領域,看好潛在利潤率增長空間,預期將推動盈利增長優於預期,以及獲得估值重評。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.